These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 12773249

  • 1. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
    Deng H, Zhao ZX, Xu QH, Zhou YP, Chen YM, Yao JL.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):305-8. PubMed ID: 12773249
    [Abstract] [Full Text] [Related]

  • 2. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O, Tamer A, Tahtaci M, Vardi S, Celebi H.
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [Abstract] [Full Text] [Related]

  • 4. Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy.
    Jang MK, Chung YH, Choi MH, Kim JA, Ryu SH, Shin JW, Kim IS, Park NH, Lee HC, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1363-8. PubMed ID: 15610309
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH, Deng X, Chen XC, Zhou BP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
    [Abstract] [Full Text] [Related]

  • 6. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L, Thabut D, Zoulim F, Andreani T, Chazouillères O, Carbonell N, Loria A, Poupon R.
    Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
    [Abstract] [Full Text] [Related]

  • 7. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH, Yu SK, Seo YS, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH, Byun KS.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1220-5. PubMed ID: 17532786
    [Abstract] [Full Text] [Related]

  • 12. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy.
    Akyuz F, Kaymakoglu S, Demir K, Aksoy N, Karaca C, Danalioglu A, Onel D, Badur S, Besisik F, Cakaloglu Y, Okten A.
    Acta Gastroenterol Belg; 2007 Aug; 70(1):20-4. PubMed ID: 17619534
    [Abstract] [Full Text] [Related]

  • 13. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
    Akarca US, Ersoz G, Gunsar F, Karasu Z, Saritas E, Yuce G, Batur Y.
    Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
    [Abstract] [Full Text] [Related]

  • 14. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
    Sarin SK, Kumar M, Hissar S, Sharma BC.
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
    [Abstract] [Full Text] [Related]

  • 15. A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China.
    Yao GB, Zhu M, Cui ZY, Wang BE, Yao JL, Zeng MD.
    J Dig Dis; 2009 May; 10(2):131-7. PubMed ID: 19426396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*.
    Sarin SK, Sandhu BS, Sharma BC, Jain M, Singh J, Malhotra V.
    J Viral Hepat; 2004 Nov; 11(6):552-8. PubMed ID: 15500556
    [Abstract] [Full Text] [Related]

  • 20. [Viral breakthrough in HBeAg-negative chronic hepatitis B patients receiving lamivudine therapy].
    Chang YJ, Yim JY, Cho NY, Choi CW, Baek SJ, Ahn SH, Choi DW, Kwon YD, Kim SS, Kwon OS, Kim JH, Yeon JE, Song JW, Byun KS, Lee CH.
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):397-404. PubMed ID: 12506244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.